A New Approach to Predict Progression-free Survival in Stage IV EGFR-mutant NSCLC Patients with EGFR-TKI TherapyJiangdian Song, Jie Tian, Kun Wang et al.|Clinical Cancer Research|2018Cited by 198
Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon responseJingwen Lin, Huiping Yang, Chao Tang et al.|Cell Host & Microbe|2021Cited by 140
Diminishing microbiome richness and distinction in the lower respiratory tract of lung cancer patients: A multiple comparative study design with independent validationJing Jin, Yuncui Gan, Huayong Liu et al.|Lung Cancer|2019Cited by 102